IOVS News in Physiological Sciences
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2005;46:1940-1947.)
© 2005 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-1203

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shoshani, Y.
Right arrow Articles by Solomon, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shoshani, Y.
Right arrow Articles by Solomon, A.

Increased Expression of Inflammatory Cytokines and Matrix Metalloproteinases in Pseudophakic Corneal Edema

Yochai Shoshani,1 Jacob Pe’er,1 Victoria Doviner,2 Joseph Frucht-Pery,1 and Abraham Solomon1

1From the Departments of Ophthalmology and 2Pathology, Hadassah University Hospital, the Hebrew University–Hadassah School of Medicine, Jerusalem, Israel.

PURPOSE. To evaluate the expression of inflammatory cytokines and matrix metalloproteinases in the corneal epithelium in pseudophakic corneal edema (PCE).

METHODS. Tissue sections were prepared from formalin-fixed, paraffin-embedded blocks of corneal buttons removed from 20 patients with PCE during penetrating keratoplasty (PKP) and from 11 age-matched control eyes enucleated because of uveal melanoma. Expression of interleukin (IL)-1ß, -6, and -8; vascular endothelial growth factor (VEGF); and matrix metalloproteinase (MMP)-1, -3, and -9 proteins in the corneal epithelium was evaluated by immunohistochemistry. Digital image analysis was performed to quantify the expression of the various cytokines and MMPs. A mean intensity stain index (ISI), based on the staining density and the area stained, was calculated from digital images captured from sequential areas of the corneal epithelium.

RESULTS. The expression of most of the inflammatory cytokines and MMPs was significantly higher in the corneal epithelium of PCE corneal buttons than in the control specimens. MMP-9 had the highest expression when compared with the control (ISI = 55.08 ± 23.71 in PCE compared with 0.169 ± 0.156 in the control; P < 0.0001). Significantly higher ISIs were also recorded for MMP-1 (16.14 ± 8.49 vs. 1.13 ± 1.79; P < 0.0001), IL-1ß (62.62 ± 27.23.97 vs. 1.61 ± 1.27; P < 0.0001), IL-8 (37.91 ± 21.18 vs. 4.24 ± 3.60; P < 0.0001), and VEGF (81.67 ± 26.22 vs. 19.40 ± 16.85; P = 0.0001). The expression of MMP-3, IL-6, and TNF-{alpha} in PCE was not different from control expression. Significant positive correlations were found between the expression of IL-1ß and MMP-9 (r2 = 0.37; P = 0.015), between VEGF and IL-8 (r2 = 0.22; P = 0.042), and a significant correlation was found between the expression of MMP-3 and TNF-{alpha} (r2 = 0.5197; P = 0.0007). The expression of TNF-{alpha} correlated significantly with the patient’s age (r2 = 0.28; P = 0.0195).

CONCLUSIONS. The corneal epithelium in PCE expresses high levels of cytokines and matrix-degrading enzymes, which are associated with inflammation, wound healing, angiogenesis, and tissue degradation. The expression of these mediators may partially explain the pathologic features associated with this disease, such as bulla formation, recurrent epithelial desquamation, and corneal neovascularization.





This article has been cited by other articles:


Home page
IOVSHome page
F. Bock, J. Onderka, T. Dietrich, B. Bachmann, F. E. Kruse, M. Paschke, G. Zahn, and C. Cursiefen
Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis
Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2545 - 2552.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Association for Research in Vision and Ophthalmology